BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McGuinness D, Kaufhold RM, McHugh PM, Winters MA, Smith WJ, Giovarelli C, He J, Zhang Y, Musey L, Skinner JM. Immunogenicity of PCV24, an expanded pneumococcal conjugate vaccine, in adult monkeys and protection in mice. Vaccine 2021;39:4231-7. [PMID: 34074546 DOI: 10.1016/j.vaccine.2021.04.067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng JZ, Lancaster C, Winters MA, Phillips KM, Zhuang P, Ha S. Multi-attribute characterization of pneumococcal conjugate vaccine by Size-exclusion chromatography coupled with UV-MALS-RI detections. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.01.042] [Reference Citation Analysis]
2 van der Put RMF, Smitsman C, de Haan A, Hamzink M, Timmermans H, Uittenbogaard J, Westdijk J, Stork M, Ophorst O, Thouron F, Guerreiro C, Sansonetti PJ, Phalipon A, Mulard LA. The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella. ACS Cent Sci . [DOI: 10.1021/acscentsci.1c01479] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Morelli L, Lay L, Santana-Mederos D, Valdes-Balbin Y, Verez Bencomo V, van Diepen A, Hokke CH, Chiodo F, Compostella F. Glycan Array Evaluation of Synthetic Epitopes between the Capsular Polysaccharides from Streptococcus pneumoniae 19F and 19A. ACS Chem Biol 2021;16:1671-9. [PMID: 34469105 DOI: 10.1021/acschembio.1c00347] [Reference Citation Analysis]